Few industries are expected to offer growth potential that’s as impressive as the cannabis industry over the next decade. But contained within the pot
Government
Federal appeals court rules against Colorado hemp firm seeking the return of its plants
A federal appeals court ruled against a Colorado hemp company trying to force Idaho authorities to release hemp seized in a January traffic stop. Big Sky
Canada’s hemp industry shrank last year amid slow-moving CBD regulations, USDA says Published 4 hours ago | By Laura Drotleff
Canada has a 20-year head start on the United States is growing and processing hemp. But Canada’s acreage shrank in 2018 as the nation
DEA affirms hemp’s new status, sends notice that plant is legal
More than six months after hemp was made legal in the United States, federal drug authorities have updated their guidance to remind law enforcement that hemp
Mitch McConnell Checks In On Hemp Legalization’s Progress (Op-Ed)
“Whatever obstacles Kentucky hemp farmers, processors, and manufacturers might encounter as they try to take full advantage of this hemp revolution, I’ll be there
Hemp Seed Bank Under Construction at Cornell University
A new proposal in the U.S. Senate would lift federal restrictions on cannabis research and direct multiple federal agencies to develop a cannabis research
Hemp for animal feed: Economic potential waits out legal maneuvering
Published August 2, 2019 | By Laura Drotleff Given hemp’s new legal status, many farmers and livestock producers want to explore cannabis for animal feed and the
USDA announces details of new Market Facilitation Program
WASHINGTON — U.S. Secretary of Agriculture Sonny Perdue has announced further details of the $16 billion Market Facilitation Program package. In May, President Donald
Big commercial hemp farm planned near Warrenton
With a big boost from its 531-acre Fauquier farm, a family-owned company aims to become Virginia’s top producer of hemp, legal for cultivation in the
Nagging hemp uncertainty takes center stage in Congress
Hemp farmers and federal health regulators are headed to the U.S. Senate on Thursday to try to clear up confusion about the newly legal